Key Highlights
- Pramana and ARUP Laboratories are partnering to digitize pathology slides and enhance AI-driven diagnostics in hematopathology.
- AI-powered algorithms will improve bone marrow biopsy assessments and workflow efficiency.
- Pramana’s SpectralHT scanners offer in-line Edge AI computing for real-time diagnostics.
- Collaboration supports commercialization and broader adoption of AI tools in pathology.
Source: Business Wire
Notable Quotes
- “Hematopathology involves highly complex and difficult-to-scan specimens, where traditional methods often fall short in delivering consistent and reproducible results. By combining our deep clinical expertise with Pramana’s large-scale digitization and AI-driven analysis, we have the ability to develop and clinically validate new AI algorithms that will improve diagnostic accuracy and workflow efficiency.” — David Ng, MD, Medical Director, Hematologic Flow Cytometry and Applied AI at ARUP Laboratories
- “This collaboration with ARUP Laboratories showcases how AI-driven pathology can redefine industry standards, making diagnostics more scalable, efficient, and interoperable. By leveraging edge computing, we’re accelerating the adoption of advanced diagnostic algorithms, including those for complex hematopathology cases.” — Prasanth Perugupalli, Chief Product Officer at Pramana
Why This Matters
The partnership between Pramana and ARUP Laboratories represents a significant step toward modernizing hematopathology diagnostics. By integrating AI-powered algorithms with real-time Edge AI computing, the collaboration enhances diagnostic precision, efficiency, and accessibility. This initiative paves the way for broader adoption of AI in clinical pathology, addressing key challenges in hematopathology and setting new industry standards for AI-driven digital pathology solutions.
